Verdesian Life Sciences
Develops technologies to improve nutrient efficiency and crop yields.
Company facts
- Founded
- 2012
- Employees
- 312
- Headquarters
- United States
- CEO
- Clare Doyle
- Type
- Private
- Funding
- Private Equity · $313M · 2021
- Subsidiaries
- Cytozyme Laboratories, QC Corporation, Biagro Western Sales
About
At Verdesian Life Sciences, we are passionate about developing leading nutrient use efficiency (NUE) technologies that help farmers and growers enhance crop performance sustainably. Our mission is clear: to enable a better future for agriculture through innovative solutions that maximize crop yields while minimizing environmental impact. We have fundamentally integrated sustainability into our business model, believing that sustainability and profitability are not mutually exclusive. Since our foundation in 2012, Verdesian has honed a portfolio of over 300 patented NUE technologies, which include biologicals, nutritional products, seed treatments, and inoculants. Each product is carefully designed to enhance nutrient uptake, reduce losses, and improve farm efficiency. We understand the challenges that farmers face, from unpredictable weather to market volatility, and we strive to provide solutions that make their lives easier and more productive. As stewards of sustainable agriculture, we take great pride in our role in helping to feed the world in a responsible way.